Tag: Corpath

COVID-19: Robotics may help to reduce exposure to virus patients during...

Studies have shown that robotic percutaneous coronary intervention (PCI) with the CorPath GRX System (Corindus, now part of Siemens Healthineers)—compared with manual PCI—reduces radiation...

Corindus Vascular Robotics announces private placement for US$45 million

Corindus Vascular Robotics has entered into a Securities Purchase Agreement pursuant to which it will issue and sell an aggregate of 67,941,346 shares of...

First commercial procedures performed with Corindus CorPath GRX system

The first commercial procedures using Corindus Vascular Robotics’ CorPath GRX system have been performed following the company’s recent 510(k) clearance from the US Food...

“Telestenting” is possible with robotic PCI

Ryan D Madder (Frederik Meijer Heart & Vascular Institute, Spectrum Health, Grand Rapids, USA) and others report in EuroIntervention that “telestenting”—ie. when the operator...

CorPath GRX robotic system receives FDA 510(k) clearance

Corindus Vascular Robotics has received 510(k) clearance from the FDA for its CorPath GRX, the second generation of its CorPath vascular robotic system. A...

TCT 2016: Breakfast symposium to explore robotic therapy in interventional cardiology

Corindus Vascular Robotics is to host a breakfast symposium entitled “Robotic Therapy—current Applications & Future Vision” on 31 October at 7.00am at the 2016...

Corindus Vascular Robotics and Acist collaborate to improve PCI workflow for...

Corindus Vascular Robotics and Acist Medical Systems have come together to provide Fairview Southdale Hospital (Edina, USA) with three leading-edge technologies that are designed...